azacitidine has been researched along with Bile Duct Neoplasms in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moolmuang, B; Ruchirawat, M; Singhirunnusorn, P | 1 |
Kim, HS; Lee, ES; Lee, JO; Lee, YM; Park, SH; Uhm, KO | 1 |
Shu, Y; Wang, B; Wang, J; Wang, JM; Zou, SQ | 1 |
Sun, HW; Tang, QB; Zou, SQ | 1 |
Henson, R; Meng, F; Mize-Berge, J; Patel, T; Wehbe, H | 1 |
Henson, R; Meng, F; Patel, T; Smith, H; Wehbe-Janek, H | 1 |
Enjoji, M; Honda, M; Nakashima, M; Nawata, H; Sakai, H | 1 |
7 other study(ies) available for azacitidine and Bile Duct Neoplasms
Article | Year |
---|---|
Effects of 5-Aza-2'-Deoxycytidine, Bromodeoxyuridine, Interferons and Hydrogen Peroxide on Cellular Senescence in Cholangiocarcinoma Cells.
Topics: Azacitidine; Bile Duct Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cellular Senescence; Cholangiocarcinoma; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA Damage; Humans; Hydrogen Peroxide; Interferons; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Cell Line, Tumor; Cholangiocarcinoma; CpG Islands; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Integrin alpha4; Integrin beta1; Lymphatic Metastasis; Male; Methyltransferases; Middle Aged; Molecular Sequence Data; Neoplasm Invasiveness; Paxillin; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sequence Analysis, DNA; Transfection | 2010 |
Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Bile Duct Neoplasms; Biomarkers, Tumor; Cholangiocarcinoma; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genes, Homeobox; Humans; Microarray Analysis | 2011 |
Inhibitory effect of methylation inhibitor 5-aza-2-deoxycytidine on bile duct cancer cell line in vivo and in vitro.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Bile Duct Neoplasms; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Hepatocytes; In Vitro Techniques; Injections, Subcutaneous; Male; Mice; Mice, Nude; Probability; Random Allocation; Sensitivity and Specificity | 2004 |
Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
Topics: 5-Methylcytosine; Azacitidine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Decitabine; DNA Methylation; ErbB Receptors; Humans; Interleukin-6; Promoter Regions, Genetic | 2006 |
Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes.
Topics: Azacitidine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; MAP Kinase Kinase Kinases; MicroRNAs; Proto-Oncogene Proteins | 2008 |
Hepatocytic phenotypes induced in sarcomatous cholangiocarcinoma cells treated with 5-azacytidine.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Differentiation; Cholangiocarcinoma; Humans; Liver; Mice; Neoplasm Transplantation; Phenotype; Transplantation, Heterologous; Tumor Cells, Cultured; Vimentin | 1997 |